KR890009907A - 강심제로서 유용한 n-하이드록시-5-페닐-2-푸란카복스 이미드아미드 - Google Patents
강심제로서 유용한 n-하이드록시-5-페닐-2-푸란카복스 이미드아미드 Download PDFInfo
- Publication number
- KR890009907A KR890009907A KR1019880016761A KR880016761A KR890009907A KR 890009907 A KR890009907 A KR 890009907A KR 1019880016761 A KR1019880016761 A KR 1019880016761A KR 880016761 A KR880016761 A KR 880016761A KR 890009907 A KR890009907 A KR 890009907A
- Authority
- KR
- South Korea
- Prior art keywords
- trifluoromethyl
- compound
- bromo
- methoxy
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (15)
- 하기 화학 일반식에 따르는 화합물 또는 이의 약제학적으로 허용되는 염 및 수화물.상기식에서, R은 존재하지 않거나, 또는 2-할로, 3-할로, 4-할로, 3-트리플루오로메틸, 4-트리플루오로메틸, 3-메틸, 3-에틸, 3-메톡시, 3-에톡시, 3-메톡시카보닐, 4-메톡시카보닐, 3-에톡시카보닐 또는 4-에톡시카보닐을 포함하는 일-, 이- 또는 삼-치환체이고; R1은 각각 독립적으로 수소 또는 저급알킬중에서 선택되며; 단, R1이 둘다 수소인 경우 R은 존재하며, 4-클로로는 아니다.
- 제1항에 있어서, R1중 하나가 수소이고 다른 하나는 수소, 메틸 또는 에틸중에서 선택되는 화합물.
- 제1항에 있어서, R1이 둘다 수소인 화합물.
- 제3항에 있어서, R이 존재지 않거나, 또는 부가적인 치환체로서 할로, 트리플루오로메틸, 메틸, 에틸, 메톡시, 에톡시, 메톡시카보닐, 에톡시카보닐, 하이드록시, 아미노 또는 니트로를 포함하는 화합물.
- 제4항에 있어서, R이 2-클로로, 3-클로로, 3-플루오로, 2-브로모, 3-브로모, 4-브로모, 3-트리플루오로메틸, 4-트리플루오로메틸, 3-메틸, 3-메톡시, 3-에톡카보닐 또는 4-에톡시카보닐을 포함하는 화합물.
- 제5항에 있어서, R이 일- 또는 이-치환체인 화합물.
- 제6항에 있어서, R이 3-트리플루오로메틸, 4-트리플루오로메틸, 3-메틸 또는 3-메톡시를 포함하는 화합물.
- 제7항에 있어서, R이 3--트리플루오로메틸인 화합물.
- 제3항에 있어서, R이 3-플루오로, 2-클로로, 3-클로로, 2-브로모, 3-브로모, 4-브로모, 3--트리플루오로메틸, 4-트리플루오로메틸, 3-메틸, 3,4-디클로로, 3-메틸-4-브로모, 3-메톡시-4-브로모, 3-클로로-4-메톡시, 3-트리플루오로메틸-4-메톡시, 3,4-디메톡시, 3-에톡시카실닐, 4-에톡시카보닐,3-트리플루오로메틸-4-하이드록시,3-트리플루오로메틸-4- 아미노, 3-트리플루오로메틸-4-니트로, 및 3-트리플루오로메틸-5-하이드록시, 이루어진 그룹중에서 선택되는 화합물.
- 제9항에 있어서, R이 3-플루오로, 3-트리플루오로메틸, 3-메틸, 3-트리플루오로메틸-4-메톡시, 3,4-디메톡시, 3-트리플루오로메틸-4-하이드록시, 3-트리플루오로메틸-4-아미노, 3-트리플루오로메틸-4-니트로 및 3-트리플루오로메틸-5-하이드록시로 이루어진 그룹중에서 선택되는 화합물.
- 제3항의 화합물 유효량 및 약제학적 담체를 함유함을 특징으로 하는 포유동물의 심장이 수축성이 증가시키는 치료를 위한 약제학적 조성물.
- 제5항의 화합물 유효량 및 약제학적 담체를 함유함을 특징으로 하는, 포유동물 심장의 수축성을 증가시키는 치료를 위한 약제학적 조성물.
- 제7항의 화합물 유효량 및 약제학적 담체를 함유함을 특징으로 하는, 포유동물 심장의 수축성을 증가시키는 치료를 위한 약제학적 조성물.
- 제8항의 화합물 유효량 및 약제학적 담체를 함유함을 특징으로 하는, 포유동물 심장의 수축성을 증가시키는 치료를 위한 약제학적 조성물.
- 제9항의 화합물 유효량 및 약제학적 담체를 함유함을 특징으로 하는, 포유동물 심장의 수축성을 증가시키는 치료를 위한 약제학적 조성물.※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US133,577 | 1987-12-16 | ||
US07/133,577 US4882354A (en) | 1987-12-16 | 1987-12-16 | N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890009907A true KR890009907A (ko) | 1989-08-04 |
Family
ID=22459299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880016761A KR890009907A (ko) | 1987-12-16 | 1988-12-16 | 강심제로서 유용한 n-하이드록시-5-페닐-2-푸란카복스 이미드아미드 |
Country Status (8)
Country | Link |
---|---|
US (1) | US4882354A (ko) |
EP (1) | EP0321431A1 (ko) |
JP (1) | JPH01265083A (ko) |
KR (1) | KR890009907A (ko) |
AU (1) | AU607659B2 (ko) |
DK (1) | DK701588A (ko) |
IL (1) | IL88673A0 (ko) |
ZA (1) | ZA889438B (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW224974B (ko) * | 1991-07-02 | 1994-06-11 | Hoffmann La Roche | |
JPH06510285A (ja) * | 1991-08-14 | 1994-11-17 | プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド | 抗不整脈及び抗細動剤として有用な環状ウレタン類 |
PL198951B1 (pl) | 1998-04-29 | 2008-08-29 | Procter & Gamble | Sposób wytwarzania 1,3-dipodstawionych-4-oksocyklicznych moczników |
ID27452A (id) * | 1998-04-29 | 2001-04-12 | Procter & Gamble | Proses untuk membuat urea 1,3-tersubstitusi-4-oksosiklik |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3985891A (en) * | 1973-02-03 | 1976-10-12 | Boehringer Ingelheim Gmbh | 2-Phenyl-imidazo (4,5-b)pyridines and salts thereof |
JPS5310974B2 (ko) * | 1974-06-10 | 1978-04-18 | ||
US3906010A (en) * | 1974-06-17 | 1975-09-16 | Morton Norwich Products Inc | Series of 5-aryl-2-furamidines |
US3946049A (en) * | 1975-04-03 | 1976-03-23 | Morton-Norwich Products, Inc. | 5-phenyl-2-furamidoximes |
US4004012A (en) * | 1975-10-14 | 1977-01-18 | Sterling Drug Inc. | 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones |
US4012416A (en) * | 1976-01-29 | 1977-03-15 | Morton-Norwich Products, Inc. | 2-[5-(3-Trifluoromethylphenyl)2-furyl]imidazole hydrochloride |
US4012414A (en) * | 1976-01-29 | 1977-03-15 | Morton-Norwich Products, Inc. | 2-(5-Phenyl-2-furyl)imidazoles |
US4012415A (en) * | 1976-01-29 | 1977-03-15 | Morton-Norwich Products, Inc. | 2-[5-(3,4-Dimethoxyphenyl)-2-furyl]imidazole hydrochloride |
US4022798A (en) * | 1976-05-10 | 1977-05-10 | Morton-Norwich Products, Inc. | 2-(5-Phenyl-2-furyl)imidazolines |
US4021444A (en) * | 1976-05-10 | 1977-05-03 | Morton-Norwich Products, Inc. | 2-[5-(3,4-Dimethoxyphenyl)-2-furyl]imidazoline hydrochloride |
IN148482B (ko) * | 1977-06-03 | 1981-03-07 | Pfizer | |
US4405635A (en) * | 1979-06-18 | 1983-09-20 | Merrell Dow Pharmaceuticals Inc. | 4-Aroylimidazol-2-ones and their use as pharmaceuticals |
US4297360A (en) * | 1980-03-28 | 1981-10-27 | Sterling Drug Inc. | 5-(Pyridinyl)pyridine-2,3-diamines, preparation thereof and their cardiotonic use |
US4397854A (en) * | 1981-05-14 | 1983-08-09 | Warner-Lambert Company | Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents |
GB8406906D0 (en) * | 1984-03-16 | 1984-04-18 | Akzo Nv | Benzo-thiazole and benzothiophene derivatives |
GB8508588D0 (en) * | 1985-04-02 | 1985-05-09 | Akzo Nv | Indene & napthalene derivatives |
-
1987
- 1987-12-16 US US07/133,577 patent/US4882354A/en not_active Expired - Lifetime
-
1988
- 1988-12-13 IL IL88673A patent/IL88673A0/xx unknown
- 1988-12-15 EP EP88870186A patent/EP0321431A1/en not_active Withdrawn
- 1988-12-16 KR KR1019880016761A patent/KR890009907A/ko not_active Application Discontinuation
- 1988-12-16 JP JP63318337A patent/JPH01265083A/ja active Pending
- 1988-12-16 AU AU27009/88A patent/AU607659B2/en not_active Expired - Fee Related
- 1988-12-16 DK DK701588A patent/DK701588A/da not_active Application Discontinuation
- 1988-12-19 ZA ZA889438A patent/ZA889438B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US4882354A (en) | 1989-11-21 |
DK701588D0 (da) | 1988-12-16 |
JPH01265083A (ja) | 1989-10-23 |
AU607659B2 (en) | 1991-03-07 |
DK701588A (da) | 1989-06-17 |
ZA889438B (en) | 1989-09-27 |
EP0321431A1 (en) | 1989-06-21 |
AU2700988A (en) | 1989-06-22 |
IL88673A0 (en) | 1989-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR940006590A (ko) | 알쯔하이머 질환 치료용 및 혈당저하제로서 유용한 화합물 | |
KR900016174A (ko) | 과혈당증 치료제로서 유용한 나프탈레닐알킬-3h-1,2,3,5-옥사티아디아졸 2-옥사이드 | |
KR870003974A (ko) | 비시클로 치환된 페닐아세토니트릴 유도체 | |
KR880006193A (ko) | 피페리딘 화합물 및 그의 제조 및 용도 | |
KR900004658A (ko) | 이치환 벤질아민, 그의 제조방법, 약제로서의 그의 용도 및 그의 합성 약제 | |
NZ194528A (en) | 4-phenoxypiperidines preparation and pharmaceutical compositions containing them | |
DE3483798D1 (de) | Dihydrodibenzocycloheptylidenethylamin-derivate. | |
KR890009907A (ko) | 강심제로서 유용한 n-하이드록시-5-페닐-2-푸란카복스 이미드아미드 | |
KR970061246A (ko) | 테스토스테론을 증가시키기 위한 약학 조성물 | |
KR900014406A (ko) | 세펨 화합물 및 이의 제조방법 | |
KR840006985A (ko) | N-치환플라본-8-카르복사미드유도체 및 그 제조방법 | |
KR900001715A (ko) | Bu-3608 유도체 | |
KR910004557A (ko) | 2,4,6-치환 페놀 유도체 | |
KR920012060A (ko) | 치환된 n-벤조일-n'-(2-페닐에틸)-피페라진 | |
ZA838558B (en) | Nitrosourea derivatives,process for the preparation thereof and pharmaceutical compositions containing them | |
KR890003368A (ko) | 특정의 치환된 페닐알킬아미노(및 아미노산) 유도체 및 기타 세로토닌농도 저하제로 오심 및 구토를 치료하는 방법 | |
KR890003755A (ko) | 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물 | |
KR880004810A (ko) | 소화성 궤양 치료제 | |
ES8305680A1 (es) | Un procedimiento para la preparacion de derivados de etanolamina. | |
ATE40948T1 (de) | Pyridylalkylnitratverbindung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
SE7500205L (ko) | ||
RU98107807A (ru) | Новые гетероциклические соединения | |
KR880000424A (ko) | 2-(5-페닐-2-푸라닐)이미다졸 | |
KR900001665A (ko) | 사이클로알킬티아졸 유도체 | |
RU98122110A (ru) | Пиридил- и пиримидил-пиперазины в лечении болезней, вызываемых злоупотреблением лекарственными и/или наркотическими веществами |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |